abstract |
The present invention concerns novel antibody-drug conjugates and the use of same in therapy, in particular in anti-cancer or anti-inflammatory therapy. The present invention also concerns useful synthesis products as linkers, consisting of a linker head and a linker body. The present invention also concerns a method for preparing the linkers and antibody-drug conjugates. |